We've updated our Privacy Policy. Questions? Email us any time at privacy@ground.newsWe've updated our Privacy Policy with additional info on research surveys, our browser extension, cookie management, and ad performance measurement. Questions? Email us any time at privacy@ground.news
Heidelberg – Endogenous dipeptides could play a new role in the treatment of diabetic complications in the future. A research consortium from the medical faculties of Heidelberg and Mannheim, as well as the Centre for Organismal Studies (COS) at Heidelberg University, is investigating which of these small protein building blocks are harmful...
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Heidelberg – Endogenous dipeptides could play a new role in the treatment of diabetic complications in the future. A research consortium from the medical faculties of Heidelberg and Mannheim, as well as the Centre for Organismal Studies (COS) at Heidelberg University, is investigating which of these small protein building blocks are harmful...